Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin regimens in metastatic colorectal cancer
NCT01131078Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2005
- Primary completion
- Nov 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bevacizumab in metastatic colorectal cancer (mCRC) (3 arms), sponsored by Roche. Primary endpoints: Time to Progression up to 5 years and Percentage of Participants With Disease Progression or Death up to 5 years. Started Jun 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01131078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01131078.